GATA2 and acute myeloid leukemia: Furthermore, while GATA2-deficient patients have profound monocytopaenia, immunodeficiency and an increased risk of myelodysplasia and acute myeloid leukaemia, none of the patients with WILD in this series had either abnormal monocyte counts or developed myelodysplasia.